2015/03/17 - Creation of a joint Inserm-Quantum Genomics laboratory at the Collège de France backed by the French National Agency for Research (ANR)

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the creation of a joint laboratory with the INSERM laboratory led by Catherine Llorens-Cortes at the Collège de France.

Download Press Release